U.S. Intraoperative Neuromonitoring Market by Source Type (Insourced Monitoring and Outsourced Monitoring), Product & Service (System, Accessory, and Service), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, and Other Surgeries), Modality (Motor Evoked Potential [MEP], Somatosensory Evoked Potential [SSEP], Electroencephalography [EEG], Electromyography [EMG], Brainstem Auditory Evoked Potential [BAEP], and Visual Evoked Potential [VEP]), and End User (Hospital and Ambulatory Surgical Center) - Opportunity Analysis and Industry Forecast, 2014-2022

August 2018 | 148 pages | ID: U69DEAB7F6DEN
Allied Market Research

Abstracts

The U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. Neuromonitoring is useful because it offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits, such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions, is reduced.

The U.S. IONM market is expected to grow at a significant rate during the forecast period, owing to growth in the aging population, increase in prevalence of chronic disorders, surge in applications of IONM in different surgeries, and rise in risk management through IONM during complex surgeries. Furthermore, stringent regulations for IONM procedures and easy availability of technologically advanced IONM systems & accessories fuel the market growth.

The U.S. IONM market is studied based on product & service, source type, application, modality, end user, and state. Based on product & service, the market is segmented into system, accessory, and service. On the basis of source type, the market is bifurcated into insourced monitoring and outsourced monitoring. As per end user, the market is categorized into hospital and ambulatory surgical center (ASC). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potential (MEP), somatosensory evoked potential (SSEP), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). As per state, the market is analyzed across California, Texas, New York, Florida, Illinois, Colorado, Louisiana, Michigan, Oklahoma, and Rest of the U.S.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all states of the U.S. is provided to determine the existing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. market.

KEY MARKET SEGMENTS

By Product & Service

• System
• Accessory
• Service

By Source Type

• Insourced monitoring
• Outsourced monitoring

By Application

• Spinal surgery
• Neurosurgery
• Vascular surgery
• ENT surgery
• Orthopedic surgery
• Other surgery

By Modality

• Motor evoked potential (MEP)
• Somatosensory evoked potential (SSEP)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potential (BAEP)
• Visual evoked potential (VEP)

By End User

• Hospital
• Ambulatory surgery center

By State

• California
• Texas
• New York
• Florida
• Illinois
• Colorado
• Louisiana
• Michigan
• Oklahoma
• Rest of the U.S.

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Accurate Monitoring, LLC.
• Computational Diagnostics, Inc.
• Intranerve, LLC.
• Inomed Medizintechnik GmbH
• Medtronic Plc
• Moberg Research, Inc. (DAYONE MEDICAL, LLC.)
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Nuvasive, Inc.
• Specialtycare

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Medsurant Health
• Abea Neurodiagnostics, Inc.
• Real Time Neuromonitoring Associates

Contents

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
  2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
  3.2.2. Top winning strategies
  3.2.3. Top player positioning, 2015
3.3. IONM PROCEDURES IN U.S., BY YEAR
3.4. MARKET DYNAMICS
  3.4.1. Drivers
    3.4.1.1. Increase in prevalence of chronic disorders
    3.4.1.2. Surge in U.S. geriatric population
    3.4.1.3. Risk management through IONM during complex surgeries
  3.4.2. Restraint
    3.4.2.1. Additional expenses associated with the insourced monitoring
  3.4.3. Opportunity
    3.4.3.1. Increase in application of IONM in different surgeries
  3.4.4. Impact Analyses

CHAPTER 4: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

4.1. Overview
  4.1.1. Market size and forecast
4.2. Insourced monitoring
  4.2.1. Key market trends, growth factors, and opportunities
  4.2.2. Market size and forecast
4.3. Outsourced monitoring
  4.3.1. Key market trends, growth factors, and opportunities
  4.3.2. Market size and forecast

CHAPTER 5: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCT & SERVICES

5.1. Overview
  5.1.1. Market size and forecast
5.2. System
  5.2.1. Market size and forecast
5.3. Accessory
  5.3.1. Market size and forecast
5.4. IONM service
  5.4.1. Market size and forecast

CHAPTER 6: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

6.1. Overview
  6.1.1. Market size and forecast
6.2. Motor evoked potentials (MEPs)
  6.2.1. Market size and forecast
6.3. Somatosensory evoked potentials (SSEPs)
  6.3.1. Market size and forecast
6.4. Electroencephalography (EEG)
  6.4.1. Market size and forecast
6.5. Electromyography (EMG)
  6.5.1. Market size and forecast
6.6. Brainstem auditory evoked potentials (BAEPs)
  6.6.1. Market size and forecast
6.7. Visual evoked potentials (VEPs)
  6.7.1. Market size and forecast

CHAPTER 7: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

7.1. Overview
  7.1.1. Market size and forecast
7.2. Spinal surgery
  7.2.1. Market size and forecast
7.3. Neurosurgery
  7.3.1. Market size and forecast
7.4. Orthopedic surgery
  7.4.1. Market size and forecast
7.5. ENT surgery
  7.5.1. Market size and forecast
7.6. Vascular surgery
  7.6.1. Market size and forecast
7.7. Other surgeries
  7.7.1. Market size and forecast

CHAPTER 8: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

8.1. Overview
  8.1.1. Market size and forecast
8.2. Hospital
  8.2.1. Market size and forecast
8.3. Ambulatory surgery Center
  8.3.1. Market size and forecast

CHAPTER 9: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY STATE

9.1. Overview
  9.1.1. Market size and forecast
9.2. California
  9.2.1. California IONM market, by application
  9.2.2. California IONM accessory market
9.3. Texas
  9.3.1. Texas IONM market, by application
  9.3.2. Texas IONM accessory market
9.4. New York
  9.4.1. New York IONM market, by application
  9.4.2. New York IONM accessory market
9.5. Florida
  9.5.1. Florida IONM market, by application
  9.5.2. Florida IONM accessory market
9.6. Illinois
  9.6.1. Illinois IONM market, by application
  9.6.2. Illinois IONM accessory market
9.7. Colorado
  9.7.1. Colorado IONM market, by application
  9.7.2. Colorado IONM accessory market
9.8. Louisiana
  9.8.1. Louisiana IONM market, by application
  9.8.2. Louisiana IONM accessory market
9.9. Michigan
  9.9.1. Michigan IONM market, by application
  9.9.2. Michigan IONM accessory market
9.10. Oklahoma
  9.10.1. Oklahoma IONM market, by application
  9.10.2. Oklahoma IONM accessory market
9.11. Rest of the U.S.
  9.11.1. Rest of the U.S. IONM market, by application
  9.11.2. Rest of the U.S. IONM accessory market

CHAPTER 10: COMPANY PROFILES

10.1. Accurate Monitoring LLC
  10.1.1. Company overview
  10.1.2. Company snapshot
  10.1.3. Operating business segments
  10.1.4. Product portfolio
  10.1.5. Business performance
10.2. Computational Diagnostics, Inc.
  10.2.1. Company overview
  10.2.2. Company snapshot
  10.2.3. Operating business segments
  10.2.4. Product portfolio
  10.2.5. Business performance
10.3. IntraNerve, LLC
  10.3.1. Company overview
  10.3.2. Company snapshot
  10.3.3. Operating business segments
  10.3.4. Product portfolio
  10.3.5. Business performance
10.4. Inomed Medizintechnik GmbH
  10.4.1. Company overview
  10.4.2. Company snapshot
  10.4.3. Operating business segments
  10.4.4. Product portfolio
  10.4.5. Business performance
  10.4.6. Key strategic moves and developments
10.5. Medtronic plc.
  10.5.1. Company overview
  10.5.2. Company snapshot
  10.5.3. Operating business segments
  10.5.4. Product portfolio
  10.5.5. Business performance
10.6. Morberg Research, Inc. (Dayone Medical, LLC.)
  10.6.1. Company overview
  10.6.2. Company snapshot
  10.6.3. Operating business segments
  10.6.4. Product portfolio
  10.6.5. Business performance
10.7. Natus Medical Incorporated
  10.7.1. Company overview
  10.7.2. Company snapshot
  10.7.3. Operating business segments
  10.7.4. Product portfolio
  10.7.5. Business performance
  10.7.6. Key strategic moves and developments
10.8. Nihon Kohden Corporation
  10.8.1. Company overview
  10.8.2. Company snapshot
  10.8.3. Operating business segments
  10.8.4. Product portfolio
  10.8.5. Business performance
  10.8.6. Key strategic moves and developments
10.9. NuVasive, Inc.
  10.9.1. Company overview
  10.9.2. Company snapshot
  10.9.3. Operating business segments
  10.9.4. Product portfolio
  10.9.5. Key strategic moves and developments
10.10. SpecialtyCare
  10.10.1. Company overview
  10.10.2. Company snapshot
  10.10.3. Operating business segments
  10.10.4. Product portfolio
  10.10.5. Business performance
  10.10.6 Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01. U.S. IONM MARKET, BY SOURCE TYPE, 2014-2022 ($MILLION)
TABLE 02. U.S. IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 03. U.S. IONM MARKET, BY MODALITY, 2014-2022 ($MILLION)
TABLE 04. U.S. IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 05. U.S. IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 06. U.S. IONM MARKET REVENUE, BY STATES, 2014-2022 ($MILLION)
TABLE 07. CALIFORNIA IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 08. TEXAS IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 09. NEW YORK IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 10. FLORIDA IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 11. ILLINOIS IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12. COLORADO IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 13. LOUISIANA IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 14. MICHIGAN IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 15. OKLAHOMA IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 16. REST OF THE U.S. IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 17. ACCURATE: COMPANY SNAPSHOT
TABLE 18. ACCURATE: PRODUCT PORTFOLIO
TABLE 19. CDI: COMPANY SNAPSHOT
TABLE 20. CDI: PRODUCT SEGMENTS
TABLE 21. CDI: PRODUCT PORTFOLIO
TABLE 22. INTRANERVE: COMPANY SNAPSHOT
TABLE 23. INTRANERVE: OPERATING SEGMENTS
TABLE 24. INTRANERVE: PRODUCT PORTFOLIO
TABLE 25. INOMED: COMPANY SNAPSHOT
TABLE 26. INOMED: OPERATING SEGMENTS
TABLE 27. INOMED: PRODUCT PORTFOLIO
TABLE 28. INOMED: KEY STRATEGIES
TABLE 29. MEDTRONIC: COMPANY SNAPSHOT
TABLE 30. MEDTRONIC: OPERATING SEGMENTS
TABLE 31. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 32. MORBERG: COMPANY SNAPSHOT
TABLE 33. MORBERG: OPERATING SEGMENTS
TABLE 34. MORBERG: PRODUCT PORTFOLIO
TABLE 35. NATUS: COMPANY SNAPSHOT
TABLE 36. NATUS: PRODUCT PORTFOLIO
TABLE 37. NATUS: KEY STRATEGIES
TABLE 38. NIHON: COMPANY SNAPSHOT
TABLE 39. NIHON: OPERATING SEGMENTS
TABLE 40. NIHON: PRODUCT PORTFOLIO
TABLE 41. NIHON: KEY STRATEGIES
TABLE 42. NUVASIVE: COMPANY SNAPSHOT
TABLE 43. NUVASIVE: PRODUCT LINE
TABLE 44. NUVASIVE: PRODUCT PORTFOLIO
TABLE 45. NUVASIVE: KEY STRATEGIES
TABLE 46. SPECIALTYCARE: COMPANY SNAPSHOT
TABLE 47. SPECIALTYCARE: OPERATING SEGMENTS
TABLE 48. SPECIALTYCARE: PRODUCT PORTFOLIO
TABLE 49. SPECIALTYCARE: KEY STRATEGIES

List Of Figures

LIST OF FIGURES

FIGURE 01. U.S. IONM MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN THE U.S. IONM MARKET
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2013-2018
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2018 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018
FIGURE 06. TOP PLAYER POSITIONING, 2015
FIGURE 07. IONM PROCEDURES IN U.S., BY YEAR
FIGURE 08. IMPACT ANALYSES
FIGURE 09. U.S. INSOURCED MONITORING MARKET, 2014-2022 ($MILLION)
FIGURE 10. U.S. OUTSOURCED MONITORING MARKET, 2014-2022 ($MILLION)
FIGURE 11. U.S. IONM SYSTEM MARKET, 2014-2022 ($MILLION)
FIGURE 12. U.S. IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 13. U.S. IONM SERVICE MARKET, 2014-2022 ($MILLION)
FIGURE 14. U.S. MOTOR EVOKED POTENTIALS (MEPS) MARKET, 2014-2022 ($MILLION)
FIGURE 15. U.S. SOMATOSENSORY EVOKED POTENTIALS (SSEPS) MARKET, 2014-2022 ($MILLION)
FIGURE 16. U.S. ELECTROENCEPHALOGRAPHY (EEG) MARKET, 2014-2022 ($MILLION)
FIGURE 17. U.S. ELECTROMYOGRAPHY (EMG) MARKET, 2014-2022 ($MILLION)
FIGURE 18. U.S. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS) MARKET, 2014-2022 ($MILLION)
FIGURE 19. U.S. VISUAL EVOKED POTENTIALS (VEPS) MARKET, 2014-2022 ($MILLION)
FIGURE 20. U.S. IONM MARKET FOR SPINAL SURGERY, 2014-2022 ($MILLION)
FIGURE 21. U.S. IONM MARKET FOR NEUROSURGERY, 2014-2022 ($MILLION)
FIGURE 22. U.S. IONM MARKET FOR ORTHOPEDIC SURGERY MARKET, 2014-2022 ($MILLION)
FIGURE 23. U.S. IONM MARKET FOR ENT SURGERY, 2014-2022 ($MILLION)
FIGURE 24. U.S. IONM MARKET FOR VASCULAR SURGERY, 2014-2022 ($MILLION)
FIGURE 25. U.S. IONM MARKET FOR OTHER SURGERIES, 2014-2022 ($MILLION)
FIGURE 26. U.S. HOSPITALS IONM MARKET, 2014-2022 ($MILLION)
FIGURE 27. U.S. AMBULATORY SURGICAL CENTERS (ASCS) IONM MARKET, 2014-2022 ($MILLION)
FIGURE 28. CALIFORNIA IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 29. TEXAS IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 30. NEW YORK IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 31. FLORIDA IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 32. ILLINOIS IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 33. COLORADO IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 34. LOUISIANA IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 35. MICHIGAN IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 36. OKLAHOMA IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 37. REST OF THE U.S. IONM ACCESSORY MARKET, 2014-2022 ($MILLION)
FIGURE 38. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. NATUS: NET SALES, 2015-2017 ($MILLION)
FIGURE 42. NATUS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. NATUS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 44. NIHON: NET SALES, 2015-2017 ($MILLION)
FIGURE 45. NIHON: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. NIHON: REVENUE SHARE BY GEOGRAPHY, 2017 (%)